2024 Q4 Form 10-Q Financial Statement
#000149315224045956 Filed on November 14, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | $0.00 | |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $127.4K | |
YoY Change | -32.93% | |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $127.4K | |
YoY Change | -32.93% | |
Operating Profit | -$127.4K | |
YoY Change | -32.01% | |
Interest Expense | $952.8K | |
YoY Change | 25.37% | |
% of Operating Profit | ||
Other Income/Expense, Net | $952.8K | |
YoY Change | 25.22% | |
Pretax Income | $825.4K | |
YoY Change | 44.8% | |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $825.4K | |
YoY Change | 43.93% | |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.09 | |
COMMON SHARES | ||
Basic Shares Outstanding | 9.167M shares | 9.167M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $271.9K | |
YoY Change | -45.63% | |
Cash & Equivalents | $271.8K | |
Short-Term Investments | ||
Other Short-Term Assets | $25.15K | |
YoY Change | -79.04% | |
Inventory | ||
Prepaid Expenses | $25.15K | |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $297.0K | |
YoY Change | -52.24% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $74.24M | |
YoY Change | 5.38% | |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $74.24M | |
YoY Change | 5.37% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $297.0K | |
Total Long-Term Assets | $74.24M | |
Total Assets | $74.53M | |
YoY Change | 4.87% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $209.1K | |
YoY Change | 131.64% | |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $284.1K | |
YoY Change | 214.72% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | ||
YoY Change | ||
Total Long-Term Liabilities | $0.00 | |
YoY Change | ||
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $284.1K | |
Total Long-Term Liabilities | $0.00 | |
Total Liabilities | $284.1K | |
YoY Change | 214.72% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | $12.65K | |
YoY Change | -97.62% | |
Common Stock | $227.00 | |
YoY Change | 0.0% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $12.88K | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $74.53M | |
YoY Change | 4.87% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $825.4K | |
YoY Change | 43.93% | |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$790.00 | |
YoY Change | -99.64% | |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | |
YoY Change | -100.0% | |
NET CHANGE | ||
Cash From Operating Activities | -790.0 | |
Cash From Investing Activities | ||
Cash From Financing Activities | 0.000 | |
Net Change In Cash | -790.0 | |
YoY Change | -100.16% | |
FREE CASH FLOW | ||
Cash From Operating Activities | -$790.00 | |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Bowen Acquisition Corp | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
420 Lexington Ave | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 2446 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10170 | ||
dei |
City Area Code
CityAreaCode
|
(203) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
998-5540 | ||
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
402534 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001973056 | ||
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Entity File Number
EntityFileNumber
|
001-41741 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
9166500 | shares |
CY2024Q3 | us-gaap |
Cash
Cash
|
271847 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
25152 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
284120 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
284120 | usd |
CY2024Q3 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
74237487 | usd |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
227 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
12652 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12879 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
74534486 | usd |
CY2024Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
127429 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
786362 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
265404 | usd |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
79481 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
103860 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
103860 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
71419358 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
402307 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
402534 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
71925752 | usd |
CY2023Q3 | us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
187428 | usd |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
190533 | usd | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-187428 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-190533 | usd | |
CY2023Q3 | BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
760871 | usd |
BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
760871 | usd | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
760871 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
760871 | usd | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
573444 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
570338 | usd | |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2023Q4 | BOWN |
Payable To Target
PayableToTarget
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
usd | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
usd | ||
us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
BOWN |
Proceeds From Issuance Of Founder Shares
ProceedsFromIssuanceOfFounderShares
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | ||
BOWN |
Payments Of Underwriters Discount
PaymentsOfUnderwritersDiscount
|
usd | ||
BOWN |
Proceeds From Private Placement
ProceedsFromPrivatePlacement
|
usd | ||
BOWN |
Payment Of Offering Costs
PaymentOfOfferingCosts
|
usd | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | ||
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | |
BOWN |
Offering Cost Paid By Target Company
OfferingCostPaidByTargetCompany
|
usd | ||
BOWN |
Noncash Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
|
usd | ||
BOWN |
Noncash Offering Costs Adjusted From Prepaid Expenses
NoncashOfferingCostsAdjustedFromPrepaidExpenses
|
usd | ||
BOWN |
Non Cash Offering Costs Charged To Additional Paidin Capital
NonCashOfferingCostsChargedToAdditionalPaidinCapital
|
usd | ||
BOWN |
Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
|
usd | ||
BOWN |
Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
usd | ||
BOWN |
Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
|
usd | ||
CY2024Q3 | BOWN |
Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
|
usd | |
BOWN |
Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
|
usd | ||
dei |
Entity Listing Par Value Per Share
EntityListingParValuePerShare
|
0.0001 | ||
CY2023Q4 | us-gaap |
Cash
Cash
|
426913 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
296999 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
506394 | usd |
CY2024Q3 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
74237487 | usd |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
71419358 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
74534486 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
71925752 | usd |
CY2024Q3 | BOWN |
Payable To Target
PayableToTarget
|
75000 | usd |
CY2024Q3 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
CY2023Q4 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
CY2024Q3 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.76 | |
CY2023Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
10.35 | |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2266500 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2266500 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2266500 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2266500 | shares |
CY2024Q3 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
CY2023Q4 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
227 | usd |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
389655 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-127429 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-389655 | usd | |
CY2024Q3 | BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
952787 | usd |
BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
2818129 | usd | |
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
952787 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
2818129 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
825358 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
2428474 | usd | |
CY2024Q1 | BOWN |
Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
|
-923492 | usd |
CY2024Q2 | BOWN |
Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
|
-941850 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
816754 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
140308 | usd |
CY2024Q3 | BOWN |
Subsequent Measurement Of Common Stock Subject To Possible Redemption Interest Earned On Trust Account
SubsequentMeasurementOfCommonStockSubjectToPossibleRedemptionInterestEarnedOnTrustAccount
|
-952787 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
825358 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
12879 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
25000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1016000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3105 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3105 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1037895 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1037895 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1037895 | usd |
CY2023Q3 | BOWN |
Stock Issued During Period Value Proceeds From Sale Of Public Units
StockIssuedDuringPeriodValueProceedsFromSaleOfPublicUnits
|
60000000 | usd |
CY2023Q3 | BOWN |
Stock Issued During Period Value Proceeds From Overallotment
StockIssuedDuringPeriodValueProceedsFromOverallotment
|
9000000 | usd |
CY2023Q3 | BOWN |
Stock Issued During Period Value Sale Of Private Units
StockIssuedDuringPeriodValueSaleOfPrivateUnits
|
3300000 | usd |
CY2023Q3 | BOWN |
Stock Issued During Period Value Overallotment Of Private Units
StockIssuedDuringPeriodValueOverallotmentOfPrivateUnits
|
315000 | usd |
CY2023Q3 | BOWN |
Adjustments To Additional Paid In Capital Underwriters Commission On Sale Of Public Units
AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnSaleOfPublicUnits
|
-1500000 | usd |
CY2023Q3 | BOWN |
Adjustments To Additional Paid In Capital Underwriters Commission On Overallotment
AdjustmentsToAdditionalPaidInCapitalUnderwritersCommissionOnOverallotment
|
-225000 | usd |
CY2023Q3 | BOWN |
Adjustments To Additional Paid In Capital Other Offering Costs
AdjustmentsToAdditionalPaidInCapitalOtherOfferingCosts
|
-1518898 | usd |
CY2023Q3 | BOWN |
Stock Issued During Period Value Initial Measurement Of Ordinary Shares
StockIssuedDuringPeriodValueInitialMeasurementOfOrdinaryShares
|
-65236367 | usd |
CY2023Q3 | BOWN |
Adjustments To Additional Paid In Capital Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalAllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
3066958 | usd |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
|
-7520591 | usd |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
-760871 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
573444 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
573444 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
531570 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
531570 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
2428474 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
570338 | usd | |
BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
2818129 | usd | |
BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
760871 | usd | |
BOWN |
Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
|
160094 | usd | |
BOWN |
Increase Decrease In Accrued Offering Costs And Expenses
IncreaseDecreaseInAccruedOfferingCostsAndExpenses
|
93383 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
40445 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-34050 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
120720 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-155066 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-217870 | usd | |
us-gaap |
Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
|
69690000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-69690000 | usd | |
BOWN |
Proceeds From Issuance Of Founder Shares
ProceedsFromIssuanceOfFounderShares
|
2520 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
69000000 | usd | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
3615000 | usd | |
BOWN |
Payments Of Underwriters Discount
PaymentsOfUnderwritersDiscount
|
1725000 | usd | |
BOWN |
Proceeds From Private Placement
ProceedsFromPrivatePlacement
|
-151318 | usd | |
BOWN |
Payment Of Offering Costs
PaymentOfOfferingCosts
|
332204 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
70408998 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-155066 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
501128 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
426913 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
271847 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
501128 | usd |
BOWN |
Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
|
2818129 | usd | |
BOWN |
Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
|
760871 | usd | |
BOWN |
Offering Cost Paid By Target Company
OfferingCostPaidByTargetCompany
|
75000 | usd | |
BOWN |
Noncash Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
NoncashOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
|
25000 | usd | |
BOWN |
Noncash Offering Costs Adjusted From Prepaid Expenses
NoncashOfferingCostsAdjustedFromPrepaidExpenses
|
894 | usd | |
BOWN |
Non Cash Offering Costs Charged To Additional Paidin Capital
NonCashOfferingCostsChargedToAdditionalPaidinCapital
|
1518898 | usd | |
BOWN |
Reclassification Of Ordinary Shares Subject To Redemption
ReclassificationOfOrdinarySharesSubjectToRedemption
|
65236367 | usd | |
BOWN |
Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
|
3066958 | usd | |
BOWN |
Remeasurement Adjustment On Ordinary Shares Subject To Possible Redemption
RemeasurementAdjustmentOnOrdinarySharesSubjectToPossibleRedemption
|
7520591 | usd | |
CY2024Q3 | us-gaap |
Cash
Cash
|
271847 | usd |
CY2024Q3 | BOWN |
Working Capital Deficit
WorkingCapitalDeficit
|
12879 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_844_eus-gaap--UseOfEstimates_zWmafGCKWf6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_862_zQn6z7kMJgn2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statement in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2024Q3 | us-gaap |
Cash
Cash
|
271847 | usd |
CY2023Q4 | us-gaap |
Cash
Cash
|
426913 | usd |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2024Q3 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
74237487 | usd |
CY2023Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
71419358 | usd |
CY2024Q3 | BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
952787 | usd |
BOWN |
Interest Earned On Investments Held In Trust Account
InterestEarnedOnInvestmentsHeldInTrustAccount
|
2818129 | usd | |
CY2024Q3 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2024Q3 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2023Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
825358 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
573444 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
2428474 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
570338 | usd | |
CY2024Q3 | BOWN |
Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
|
952787 | usd |
CY2023Q3 | BOWN |
Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
|
760871 | usd |
BOWN |
Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
|
2818129 | usd | |
BOWN |
Accretion Of Temporary Equity Into Redemption Value Interest Earned
AccretionOfTemporaryEquityIntoRedemptionValueInterestEarned
|
760871 | usd | |
CY2023Q3 | BOWN |
Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
|
7520591 | usd |
BOWN |
Accretion Of Temporary Equity Into Redemption Value
AccretionOfTemporaryEquityIntoRedemptionValue
|
7520591 | usd | |
CY2024Q3 | BOWN |
Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
|
-127429 | usd |
CY2023Q3 | BOWN |
Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
|
-7708018 | usd |
BOWN |
Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
|
-389655 | usd | |
BOWN |
Net Loss Including Accretion Of Equity Into Redemption Value
NetLossIncludingAccretionOfEquityIntoRedemptionValue
|
-7711124 | usd | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zYzBp13LZLRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_z73ZPC9Ej5Gh">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_iI_c20240930_zuExcTvHBmg" title="Cash FDIC insured amount">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2024Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2023Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
|
71419358 | usd |
BOWN |
Subsequent Measurement Of Ordinary Shares Subject To Possible Redemption
SubsequentMeasurementOfOrdinarySharesSubjectToPossibleRedemption
|
2818129 | usd | |
CY2024Q3 | us-gaap |
Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
|
74237487 | usd |
us-gaap |
Payments For Fees
PaymentsForFees
|
75000 | usd | |
CY2023Q1 | BOWN |
Equity Securities Fv Ni Term
EquitySecuritiesFvNiTerm
|
P1Y10M2D | |
CY2024Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
30000 | usd |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
90000 | usd | |
CY2023Q3 | us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
26667 | usd |
us-gaap |
Administrative Fees Expense
AdministrativeFeesExpense
|
26667 | usd | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2266500 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2266500 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2266500 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2266500 | shares |
CY2024Q3 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
CY2023Q4 | BOWN |
Ordinary Shares Subject To Redemption
OrdinarySharesSubjectToRedemption
|
6900000 | shares |
us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
each holder of a right will automatically receive one-tenth (1/10) of one ordinary share upon consummation of the initial Business Combination | ||
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |